Hiroshima University Hospital ( Site 0156)

Hiroshima 734-8551

0 studies enrolling now · 1 studies all time

What they study most

Advanced Hepatocellular Carcinoma

Studies at this site

• Safety and Efficacy of Coformulated Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib (E7080/MK-7902) in Advanced Hepatocellular Carcinoma (MK-1308A-004) — Completed